People with knowledge of the process, who asked not to be named, say Greenpeak Partners has started approaching buyers for Academia and sent out information materials this week. Early talk points to a price tag topping €1 billion, or about $1.1 billion.
Talks are still at the starting line, so the process may not culminate in a transaction. Greenpeak and Macquarie representatives declined to comment.
Headquartered in Munich, Greenpeak created Academia in 2021 to collaborate with laboratories across Germany. The group focuses on pathology, human genetics and hemostaseology.
In a recent report, Bloomberg Intelligence analyst Stuart Gordon estimates the global testing market at about $300 billion, citing Eurofins Scientific SE, SGS SA and Bureau Veritas SA as key players. Eurofins projects the industry will expand at a 6.9 percent annual rate to reach $468 billion by 2032.
New information about assets can prompt investors to reassess opportunities and seek an edge. We're hosting our first ever investor livestream on 11/17 to show you how to use ChatGPT and Claude to invest like a pro, hosted by Briefs Finance CEO Jaspreet Singh. Save your seat.
Why does that matter? A sale outcome near the whispered level would add another data point for valuations across diagnostics and lab services, a slice of the market with sizable incumbents and a long runway if those growth forecasts hold.
Smart investors welcome new tools and perspectives to make more confident decisions. On 11/17, our CEO Jaspreet Singh goes live for our first ever investor livestream on how to use ChatGPT and Claude to invest like a pro. Register to join him.
How To Use ChatGPT & Claude To Research Stocks Like A Pro
You’re in!
Make sure to check your inbox for the first email.
Before you go
We’re hosting our first ever livestream on how investors can use ChatGPT & Claude to invest like a pro. It’s on 11/17 and is hosted by our CEO Jaspreet Singh.
Click here to join →
